Peter P. Pfreundschuh
2016 - Immunomedics
In 2016, Peter P. Pfreundschuh earned a total compensation of $524.5K as Former VP Finance and Chief Financial Officer at Immunomedics, a 13% decrease compared to previous year.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Option Awards | $60,000 |
| Salary | $316,267 |
| Other | $123,192 |
| Total | $524,459 |
Pfreundschuh received $316.3K in salary, accounting for 60% of the total pay in 2016.
Pfreundschuh also received $25K in bonus, $60K in option awards and $123.2K in other compensation.
Rankings
In 2016, Peter P. Pfreundschuh's compensation ranked 11,010th out of 14,075 executives tracked by ExecPay. In other words, Pfreundschuh earned more than 21.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,010 out of 14,075 | 22nd |
Division Manufacturing | 4,279 out of 5,486 | 22nd |
Major group Chemicals And Allied Products | 1,531 out of 1,900 | 19th |
Industry group Drugs | 1,234 out of 1,543 | 20th |
Industry In Vitro and In Vivo Diagnostic Substances | 46 out of 65 | 29th |
Source: SEC filing on November 2, 2016.
Pfreundschuh's colleagues
We found three more compensation records of executives who worked with Peter P. Pfreundschuh at Immunomedics in 2016.
News
Korro Bio CEO David Lucchino's 2020 pay falls 29% to $5.2M
April 29, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett receives $26M in 2019
April 29, 2020
UroGen Pharma Ltd. CEO Ron Bentsur's 2018 pay jumps 202% to $6M
April 26, 2019